Paper24676901
Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
Camilio KA and 4 others. Cancer Immunol Immunother, 2014. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315. Papers, record 24676901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24676901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimicrobial Cationic Peptides | Major topic |
| Lactoferrin | Major topic |
| Melanoma, Experimental | Major topic |
| Peptide Fragments | Major topic |
| Animals | |
| Blotting, Western | |
| Cattle | |
| Cells, Cultured | |
| Cytokines | |
| Female | |
| Hemolysis | |
| Humans | |
| Inflammation | |
| Inflammation Mediators | |
| Lymphocytes, Tumor-Infiltrating | |
| Melanoma | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Nude |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15210788 | High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. | J Immunol | 2004 | https://conductscience.org/library/papers/15210788 | PubMed |
| 2 | 6251537 | Surface configuration of human tumor cells obtained by fine needle aspiration biopsy. | Scan Electron Microsc | 1980 | https://conductscience.org/library/papers/6251537 | PubMed |
| 3 | 14640919 | Systemic chemotherapy in the treatment of malignant melanoma. | Expert Opin Pharmacother | 2003 | https://conductscience.org/library/papers/14640919 | PubMed |
| 4 | 11390444 | Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. | J Immunol | 2001 | https://conductscience.org/library/papers/11390444 | PubMed |
| 5 | 10901303 | In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. | Anticancer Drug Des | 2000 | https://conductscience.org/library/papers/10901303 | PubMed |
| 6 | 7477296 | Cloning of a new cytokine that induces IFN-gamma production by T cells. | Nature | 1995 | https://conductscience.org/library/papers/7477296 | PubMed |
| 7 | 11312119 | Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. | Cytokine Growth Factor Rev | 2001 | https://conductscience.org/library/papers/11312119 | PubMed |
| 8 | 14959890 | The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. | J Pept Sci | 2004 | https://conductscience.org/library/papers/14959890 | PubMed |
| 9 | 4953423 | Treatment of malignant melanoma. | CA Cancer J Clin | 1965 | https://conductscience.org/library/papers/4953423 | PubMed |
| 10 | 19835863 | Cationic amphiphilic peptides with cancer-selective toxicity. | Eur J Pharmacol | 2009 | https://conductscience.org/library/papers/19835863 | PubMed |
| 11 | 5934973 | Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities. | J Bacteriol | 1966 | https://conductscience.org/library/papers/5934973 | PubMed |
| 12 | 22350184 | Upcoming strategies for the treatment of metastatic melanoma. | Arch Dermatol Res | 2012 | https://conductscience.org/library/papers/22350184 | PubMed |
| 13 | 11807545 | Antimicrobial peptides of multicellular organisms. | Nature | 2002 | https://conductscience.org/library/papers/11807545 | PubMed |
| 14 | 21802280 | New drugs in melanoma: it's a whole new world. | Eur J Cancer | 2011 | https://conductscience.org/library/papers/21802280 | PubMed |
| 15 | 19302047 | Immunological and inflammatory functions of the interleukin-1 family. | Annu Rev Immunol | 2009 | https://conductscience.org/library/papers/19302047 | PubMed |
| 16 | 15024351 | Intralesional chemotherapy for head and neck carcinoma: a review of the literature. | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | 2004 | https://conductscience.org/library/papers/15024351 | PubMed |
| 17 | 21945565 | Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs. | Chem Phys Lipids | 2011 | https://conductscience.org/library/papers/21945565 | PubMed |
| 18 | 22800543 | Update on the current state of melanoma incidence. | Dermatol Clin | 2012 | https://conductscience.org/library/papers/22800543 | PubMed |
| 19 | 16648838 | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. | Nature | 2006 | https://conductscience.org/library/papers/16648838 | PubMed |
| 20 | 7669927 | Scanning electron microscopic analysis of breast aspirates. | Cytopathology | 1995 | https://conductscience.org/library/papers/7669927 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42576411 | Antimicrobial Peptides of the Skin: Roles in Skin Cancer and Clinical Applications. | Exp Dermatol | 2026 | https://conductscience.org/library/papers/42576411 | PubMed |
| 42449973 | Lactoferrin-Derived Peptides in Cancer Therapy: Structural Features, Mechanistic Insights and Clinical Translation Prospects. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42449973 | PubMed |
| 41756527 | Ultrasound-propelled oncolytic biomimetic microbubbles as in situ vaccines reprogram tumor immunosuppressive microenvironment. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41756527 | PubMed |
| 41672596 | Immunobiological mechanisms of action of oncolytic peptides. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41672596 | PubMed |
| 40342581 | Cationic antimicrobial peptides: potential templates for anticancer agents. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40342581 | PubMed |
| 40038239 | Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40038239 | PubMed |
| 39411968 | Doramectin Induces Apoptosis in B16 Melanoma Cells. | Anticancer Agents Med Chem | 2025 | https://conductscience.org/library/papers/39411968 | PubMed |
| 39000371 | Biological Activity of Natural and Synthetic Peptides as Anticancer Agents. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000371 | PubMed |
| 38681568 | Enhancing the therapeutic impact of sublethal radiofrequency hyperthermia in malignant solid tumor treatment. | Heliyon | 2024 | https://conductscience.org/library/papers/38681568 | PubMed |
| 38545099 | LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells. | Front Immunol | 2024 | https://conductscience.org/library/papers/38545099 | PubMed |
| 38344173 | From antimicrobial to anticancer: unraveling the potential of pleurocidin and pleurocidin-derived peptides in the treatment of cancers. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38344173 | PubMed |
| 38125722 | LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma. | Oncoimmunology | 2024 | https://conductscience.org/library/papers/38125722 | PubMed |
| 38006049 | Immunotherapeutic Agents for Intratumoral Immunotherapy. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38006049 | PubMed |
| 38003414 | Biophysical Insights into the Antitumoral Activity of Crotalicidin against Breast Cancer Model Membranes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003414 | PubMed |
| 37637082 | From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy. | Bioact Mater | 2024 | https://conductscience.org/library/papers/37637082 | PubMed |
| 37505037 | ΔM4: Membrane-Active Peptide with Antitumoral Potential against Human Skin Cancer Cells. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/37505037 | PubMed |
| 36614022 | Understanding the Biophysical Interaction of LTX-315 with Tumoral Model Membranes. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36614022 | PubMed |
| 36551579 | Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551579 | PubMed |
| 36450380 | Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/36450380 | PubMed |
| 36428530 | In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis. | Biomedicines | 2022 | https://conductscience.org/library/papers/36428530 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24676901
GET https://conductscience.org/api/papers/v1/24676901/references?page=2